1
|
De Wolf J, Fadel G, Olland A, Falcoz PE, Mordant P, Castier Y, Brioude G, Thomas PA, Lacoste P, Issard J, Antoine C, Fadel E, Chapelier A, Mercier O, Sage E. Controlled donation after circulatory death lung transplantation: Results of the French protocol including in situ abdominal normothermic regional perfusion and ex vivo lung perfusion. J Heart Lung Transplant 2023; 42:1093-1100. [PMID: 37019731 DOI: 10.1016/j.healun.2023.03.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 01/30/2023] [Accepted: 03/06/2023] [Indexed: 03/16/2023] Open
Abstract
BACKGROUND The French national protocol for controlled donation after circulatory determination of death (cDCD) includes normothermic regional perfusion (NRP) in case of abdominal organ procurement and additional ex-vivo lung perfusion (EVLP) before considering lung transplantation (LT). METHODS We made a retrospective study of a prospective registry that included all donors considered for cDCD LT from the beginning of the program in May 2016 to November 2021. RESULTS One hundred grafts from 14 donor hospitals were accepted by 6 LT centers. The median duration of the agonal phase was 20 minutes [2-166]. The median duration from circulatory arrest to pulmonary flush was 62 minutes [20-90]. Ten lung grafts were not retrieved due to prolonged agonal phases (n = 3), failure of NRP insertion (n = 5), or poor in situ evaluation (n = 2). The remaining 90 lung grafts were all evaluated on EVLP, with a conversion rate of 84% and a cDCD transplantation rate of 76%. The median total preservation time was 707 minutes [543-1038]. Seventy-one bilateral LTs and 5 single LTs were performed for chronic obstructive pulmonary disease (n = 29), pulmonary fibrosis (n = 21), cystic fibrosis (n = 15), pulmonary hypertension (n = 8), graft-versus-host disease (n = 2), and adenosquamous carcinoma (n = 1). The rate of PGD3 was 9% (n = 5). The 1-year survival rate was 93.4%. CONCLUSION After initial acceptance, cDCD lung grafts led to LT in 76% of cases, with outcomes similar to those already reported in the literature. The relative impacts of NRP and EVLP on the outcome following cDCD LT should be assessed prospectively in the context of comparative studies.
Collapse
Affiliation(s)
- J De Wolf
- Department of Thoracic Surgery and Lung Transplantation, Hôpital Foch, Suresnes, France
| | - G Fadel
- Department of Thoracic Surgery and Lung Transplantation, Hôpital Foch, Suresnes, France
| | - A Olland
- Department of Thoracic Surgery and Lung Transplantation, Centre Hospitalier Universitaire de Strasbourg Strasbourg, France
| | - P E Falcoz
- Department of Thoracic Surgery and Lung Transplantation, Centre Hospitalier Universitaire de Strasbourg Strasbourg, France
| | - P Mordant
- Department of Vascular Surgery, Thoracic Surgery and Lung Transplantation, Hôpital Bichat, Assistance Publique - Hôpitaux de Paris, Université de Paris Cité, Paris, France
| | - Y Castier
- Department of Vascular Surgery, Thoracic Surgery and Lung Transplantation, Hôpital Bichat, Assistance Publique - Hôpitaux de Paris, Université de Paris Cité, Paris, France
| | - G Brioude
- Department of Thoracic Surgery and Lung Transplantation, Hopital Nord de Marseille APHM, Marseille, France
| | - P A Thomas
- Department of Thoracic Surgery and Lung Transplantation, Hopital Nord de Marseille APHM, Marseille, France
| | - P Lacoste
- Department of Thoracic Surgery and Lung Transplantation, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - J Issard
- Department of Thoracic Surgery and Lung Transplantation, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
| | - C Antoine
- Agence de la Biomédecine, Saint-Denis, France
| | - E Fadel
- Department of Thoracic Surgery and Lung Transplantation, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
| | - A Chapelier
- Department of Thoracic Surgery and Lung Transplantation, Hôpital Foch, Suresnes, France
| | - O Mercier
- Department of Thoracic Surgery and Lung Transplantation, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
| | - E Sage
- Department of Thoracic Surgery and Lung Transplantation, Hôpital Foch, Suresnes, France.
| |
Collapse
|
2
|
Valdeolmillos E, Pavec JL, Audie M, Savale L, Jais X, Feuillet S, Sitbon O, Mercier O, Petit J, Humbert M, Fadel E, Belli E, Hascoet S. Severe Pediatric Pulmonary Arterial Hypertension. Long-Term Outcomes of Reverse Potts Shunt and Transplantation. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Fadel G, Akamkam A, Guihaire J, Adam J, Menager J, Fadel E, Antigny F, Mercier O. Pressure Controlled Hypothermic Lung Perfusion is not Better Than Cold Storage for Lung Preservation. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Le Pavec J, Savale L, Prévot G, Montani D, Sitbon O, Fadel E, Humbert M, Mercier O. [Lung transplantation for severe pulmonary hypertension]. Rev Mal Respir 2023; 40 Suppl 1:e52-e57. [PMID: 36725440 DOI: 10.1016/j.rmr.2022.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- J Le Pavec
- Service de Pneumologie et de Transplantation Pulmonaire, Groupe hospitalier Marie-Lannelongue-Paris Saint-Joseph, Le Plessis-Robinson, France; Université Paris-Saclay, Le Kremlin Bicêtre, France; UMR_S 999, Université Paris-Sud, Inserm, Groupe hospitalier Marie-Lannelongue-Saint-Joseph, Le Plessis-Robinson, France.
| | - L Savale
- Université Paris-Saclay, Le Kremlin Bicêtre, France; UMR_S 999, Université Paris-Sud, Inserm, Groupe hospitalier Marie-Lannelongue-Saint-Joseph, Le Plessis-Robinson, France; Service de Pneumologie, Hôpital Kremlin Bicêtre, AP-HP, Kremlin Bicêtre, France
| | - G Prévot
- Pôle des voies respiratoires-Hôpital Larrey, Centre Hopitalo-Universitaire, Toulouse, France
| | - D Montani
- Université Paris-Saclay, Le Kremlin Bicêtre, France; UMR_S 999, Université Paris-Sud, Inserm, Groupe hospitalier Marie-Lannelongue-Saint-Joseph, Le Plessis-Robinson, France; Service de Pneumologie, Hôpital Kremlin Bicêtre, AP-HP, Kremlin Bicêtre, France
| | - O Sitbon
- Université Paris-Saclay, Le Kremlin Bicêtre, France; UMR_S 999, Université Paris-Sud, Inserm, Groupe hospitalier Marie-Lannelongue-Saint-Joseph, Le Plessis-Robinson, France; Service de Pneumologie, Hôpital Kremlin Bicêtre, AP-HP, Kremlin Bicêtre, France
| | - E Fadel
- Service de Pneumologie et de Transplantation Pulmonaire, Groupe hospitalier Marie-Lannelongue-Paris Saint-Joseph, Le Plessis-Robinson, France; Université Paris-Saclay, Le Kremlin Bicêtre, France; Service de Chirurgie Thoracique et Transplantation Cardio-pulmonaire, Groupe Hospitalier Marie-Lannelongue -Paris Saint-Joseph, Le Plessis-Robinson, France
| | - M Humbert
- Université Paris-Saclay, Le Kremlin Bicêtre, France; UMR_S 999, Université Paris-Sud, Inserm, Groupe hospitalier Marie-Lannelongue-Saint-Joseph, Le Plessis-Robinson, France; Service de Pneumologie, Hôpital Kremlin Bicêtre, AP-HP, Kremlin Bicêtre, France
| | - O Mercier
- Service de Pneumologie et de Transplantation Pulmonaire, Groupe hospitalier Marie-Lannelongue-Paris Saint-Joseph, Le Plessis-Robinson, France; Université Paris-Saclay, Le Kremlin Bicêtre, France; Service de Chirurgie Thoracique et Transplantation Cardio-pulmonaire, Groupe Hospitalier Marie-Lannelongue -Paris Saint-Joseph, Le Plessis-Robinson, France
| |
Collapse
|
5
|
Le Pavec J, Pison C, Hirschi S, Bunel V, Mordant P, Brugière O, Le Guen M, Olland A, Coiffard B, Renaud-Picard B, Tissot A, Brioude G, Borie R, Crestani B, Deslée G, Stelianides S, Mal H, Schuller A, Falque L, Lorillon G, Tazi A, Burgel P, Grenet D, De Miranda S, Bergeron A, Launay D, Cottin V, Nunes H, Valeyre D, Uzunhan Y, Prévot G, Sitbon O, Montani D, Savale L, Humbert M, Fadel E, Mercier O, Mornex J, Dauriat G, Reynaud-Gaubert M. Transplantation pulmonaire en France : actualisation des indications et contre-indications en 2022. Rev Mal Respir 2022; 39:855-872. [DOI: 10.1016/j.rmr.2022.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 10/18/2022] [Indexed: 11/11/2022]
|
6
|
Benítez J, JOB B, Thomas de Montpréville V, Lacroix L, Saulnier P, Arana R, Lambotte O, Mussot S, Mercier O, Fadel E, Florez-Arango J, Scoazec JY, Molina T, Besse B. MA10.08 Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs). J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
7
|
Valdeolmillos E, Boucly A, Le Pavec J, Savale L, Sitbon O, Petit J, Guirgis L, Batteux C, Cohen S, Fournier E, Humbert M, Fadel E, Belli E, Hascoët S. Prognostic value of hemodynamic parameters in pulmonary arterial hypertension associated to congenital heart diseases. Archives of Cardiovascular Diseases Supplements 2022. [DOI: 10.1016/j.acvdsp.2022.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Valdeolmillos E, Hascoët S, Le Pavec J, Audie M, Savale L, Jais X, Feuillet S, Sitbon O, Mercier O, Petit J, Humbert M, Fadel E, Belli E. Severe pediatric pulmonary arterial hypertension: Long-term outcomes of reverse Potts shunt and transplantation. Archives of Cardiovascular Diseases Supplements 2022. [DOI: 10.1016/j.acvdsp.2022.07.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
9
|
Genty T, Doré P, Bouteau A, Rezaguia-Delclaux S, Fadel E, Stephan F. Evaluation of Diaphragmatic Function After Lung Transplantation (DIATRIBE). J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
10
|
Brunet D, Van SD, Masson B, Antigny F, Haddad F, Kloeckner M, Fadel E, Mercier O, Guihaire J. Left Ventricular Diastolic Dysfunction in Chronic Thromboembolic Pulmonary Hypertension. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
11
|
Dauriat G, Pradere P, Feuillet S, Crutu A, Florea V, Hanna A, Le Pavec J, Mercier O, Fadel E. Réponse vaccinale contre la Covid en transplantation pulmonaire. Revue des Maladies Respiratoires Actualités 2022. [PMCID: PMC8709669 DOI: 10.1016/j.rmra.2021.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Introduction La vaccination contre la Covid a été recommandée chez les patients transplantés d’organes solides en début d’année 2021, selon un schéma comprenant 3 doses chez les patients n’ayant pas présenté d’infection par la Covid 19 et selon un schéma comprenant 2 injections chez les patients ayant été infectés par la Covid. Méthodes Nous avons étudié la réponse vaccinale après un schéma complet dans une cohorte de patients transplantés pulmonaires et cardiopulmonaires à l’hôpital Marie Lannelongue. Selon les recommandations de l’OMS, l’absence de réponse vaccinale est définie par une sérologie dont le taux est < 30 BAU/ml. Le taux d’Anticorps considéré comme protecteur est un taux > 260 BAU/ml. Les patients dont le taux est compris entre 30 et 260 BAU/ml sont considérés comme faiblement répondeurs. La sérologie a été effectuée entre 1 et 3 mois après la dernière injection. Résultats Dans notre cohorte comprenant 373 patients, une sérologie Covid a pu être obtenue chez 75% des patients. Une absence complète de séroconversion a été constatée chez 75% des patients. Une séroconversion avec un taux d’anticorps considéré comme protecteur n’a été obtenu que chez 14% des patients, dont la moitié a présenté une infection par la Covid. Par ailleurs, 11% des patients ont été faiblement répondeurs. Conclusion Notre étude mono-centrique suggère une très faible réponse vaccinale chez les patients transplantés pulmonaires et cardiopulmonaires, suggérant la réalisation d’une 4e dose chez les patients partiellement répondeurs et/ou un traitement par anticorps monoclonaux spécifiques chez les patients non répondeurs.
Collapse
|
12
|
Pavec J, Feuillet S, Mercier O, Pradère P, Dauriat G, Crutu A, Florea V, Savale L, Levy M, Laverdure F, Stephan F, Fabre D, Mitilian D, Boulate D, Mussot S, Hascoët S, Bonnet D, Humbert M, Fadel E. Lung and Heart-Lung Transplantation for Children with PAH: Dramatic Benefits from the Implementation of High-Priority Allocation Program in France. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
13
|
Tselikas L, Garzelli L, Mercier O, Auperin A, Lamrani L, Deschamps F, Yevich S, Roux C, Mussot S, Delpla A, Varin F, Hakime A, Teriitehau C, Le Péchoux C, Pradère P, Caramella C, Besse B, Fadel E, de Baere T. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease. Diagn Interv Imaging 2020; 102:19-26. [PMID: 33020025 DOI: 10.1016/j.diii.2020.09.006] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2020] [Revised: 08/13/2020] [Accepted: 09/01/2020] [Indexed: 12/14/2022]
Abstract
PURPOSE The purpose of this study was to compare efficacy and tolerance between radiofrequency ablation (RFA) and surgery for the treatment of oligometastatic lung disease. MATERIALS AND METHODS This retrospective study reviewed patients treated in two institutions for up to 5 pulmonary metastases with a maximal diameter of 4cm and without associated pleural involvement or thoracic lymphadenopathy. Patient demographics, tumor characteristics, treatment outcome, and length of hospital stay were compared between the two groups. Efficacy endpoints were overall survival (OS), progression-free survival (PFS) and pulmonary or local tumor progression rates. RESULTS Among 204 patients identified, 78 patients (42 men, 36 women; mean age, 53.3±14.9 [SD]; age range: 15-81 years) were treated surgically, while 126 patients (59 men, 67 women; mean age, 62.2±10.8 [SD]; age range: 33-80 years) were treated by RFA. In the RFA cohort, patients were significantly older (P<0.0001), with more extra-thoracic localisation (P=0.015) and bilateral tumour burden (P=0.0014). In comparison between surgery and RFA cohorts, respectively, the 1- and 3-year OS were 94.8 and 67.2% vs. 94 and 72.1% (P=0.46), the 1- and 3-year PFS were 49.4% and 26.1% vs. 38.9% and 14.8% (P=0.12), the pulmonary progression rates were 39.1% and 56% vs. 41.2% and 65.3% (P>0.99), and the local tumour progression rates were 5.4% and 10.6% vs. 4.8% and 18.6% (P=0.07). Tumour size>2cm was associated with a significantly higher local tumor progression in the RFA group (P=0.010). Hospitalisation stay was significantly shorter in the RFA group (median of 3 days; IQR=2 days; range: 2-12 days) than in the surgery group (median of 9 days; IQR=2 days; range: 6-21 days) (P<0.01). CONCLUSION RFA should be considered a minimally-invasive alternative with similar OS and PFS to surgery in the treatment of solitary or multiple lung metastases measuring less than 4cm in diameter without associated pleural involvement or thoracic lymphadenopathy.
Collapse
Affiliation(s)
- L Tselikas
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France; University of Paris-Saclay, 91190 Saint-Aubin, France; Institut d'Oncologie thoracique, 94805 Villejuif, France.
| | - L Garzelli
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - O Mercier
- University of Paris-Saclay, 91190 Saint-Aubin, France; Institut d'Oncologie thoracique, 94805 Villejuif, France; Department of Thoracic and Vascular Surgery, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France; Research and Innovation Unit, INSERM U999, DHU Torino, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - A Auperin
- Biostatistics and Epidemiology Unit, Gustave-Roussy INSERM 1018, 94805 Villejuif, France
| | - L Lamrani
- Research and Innovation Unit, INSERM U999, DHU Torino, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - F Deschamps
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - S Yevich
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France; Interventional Radiology, MD-Anderson, 77030 Houston, TX, USA
| | - C Roux
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - S Mussot
- Institut d'Oncologie thoracique, 94805 Villejuif, France; Department of Thoracic and Vascular Surgery, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France; Research and Innovation Unit, INSERM U999, DHU Torino, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - A Delpla
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - F Varin
- Department of Anesthesiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - A Hakime
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - C Teriitehau
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - C Le Péchoux
- Institut d'Oncologie thoracique, 94805 Villejuif, France; Department of Radiation Therapy, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - P Pradère
- Institut d'Oncologie thoracique, 94805 Villejuif, France; Department of Thoracic and Vascular Surgery, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - C Caramella
- Institut d'Oncologie thoracique, 94805 Villejuif, France; Radiology Department, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - B Besse
- University of Paris-Saclay, 91190 Saint-Aubin, France; Institut d'Oncologie thoracique, 94805 Villejuif, France; Department of Cancer Medicine, Gustave-Roussy Cancer Campus, 94805 Villejuif, France
| | - E Fadel
- University of Paris-Saclay, 91190 Saint-Aubin, France; Institut d'Oncologie thoracique, 94805 Villejuif, France; Department of Thoracic and Vascular Surgery, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France; Research and Innovation Unit, INSERM U999, DHU Torino, Marie-Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - T de Baere
- Interventional Radiology, Gustave-Roussy Cancer Campus, 94805 Villejuif, France; University of Paris-Saclay, 91190 Saint-Aubin, France; Institut d'Oncologie thoracique, 94805 Villejuif, France
| |
Collapse
|
14
|
Arthur Ataam J, Amsallem M, Contrepois K, Guihaire J, Haddad F, Dorfmuller P, Fadel E, Mercier O. Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
15
|
Amsallem M, Sweatt A, Arthur Ataam J, Mercier O, Lecerf F, Rucker-Martin C, Ghigna M, Spiekerkoetter E, Rabinovitch M, Kuznetsova T, Fadel E, Haddad F, Zamanian R. Targeted Immune and Growth Factor Proteomics of Right Heart Adaptation to Pulmonary Arterial Hypertension Reveals a Potential Role of the Hepatic Growth Factor. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1141] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
16
|
Hascoet S, Le Pavec J, De Lemos A, Pontailler M, Savale L, Mercier O, Mussot S, Feuillet S, Stephan F, Humbert M, Bonnet D, Fadel E. Outcome of Heart-Lung and Double Lung Transplantation in Pulmonary Arterial Hypertension Due to Congenital Heart Disease is Related to the Complexity of the Defects. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
17
|
Mathi K, Ataam J, Kobayashi Y, Amsallem M, Vrtovec B, Martin B, Guihaire J, Fadel E, Mercier O, Nadeau K, Maecker H, Haddad F. High Dimensional Flow Cytometry Characterization of Cardiac Allograft Vasculopathy Highlights Monocyte Activation Pathways. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
18
|
Henry B, Garraffo A, Consigny P, Lanternier F, Frange P, To N, Fadel E, Le Pavec J, Lortholary O. Travel Practices and Associated Risks in Thoracic Transplant Recipients: A Monocentric Survey. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
19
|
Gazengel P, Le Pavec J, Mercier O, Fabre D, Mussot S, Feuillet S, Petit J, Humbert M, Fadel E, Hascoët S. Combined lung transplantation and percutaneous septal defect closure for end-stage atrial septal defect associated pulmonary arterial hypertension. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
20
|
Brosseau C, Danger R, Durand M, Durand E, Foureau A, Lacoste P, Tissot A, Roux A, Reynaud-Gaubert M, Kessler R, Mussot S, Dromer C, Brugière O, Mornex JF, Guillemain R, Claustre J, Magnan A, Brouard S, Velly J, Rozé H, Blanchard E, Antoine M, Cappello M, Ruiz M, Sokolow Y, Vanden Eynden F, Van Nooten G, Barvais L, Berré J, Brimioulle S, De Backer D, Créteur J, Engelman E, Huybrechts I, Ickx B, Preiser T, Tuna T, Van Obberghe L, Vancutsem N, Vincent J, De Vuyst P, Etienne I, Féry F, Jacobs F, Knoop C, Vachiéry J, Van den Borne P, Wellemans I, Amand G, Collignon L, Giroux M, Angelescu D, Chavanon O, Hacini R, Martin C, Pirvu A, Porcu P, Albaladejo P, Allègre C, Bataillard A, Bedague D, Briot E, Casez‐Brasseur M, Colas D, Dessertaine G, Francony G, Hebrard A, Marino M, Protar D, Rehm D, Robin S, Rossi‐Blancher M, Augier C, Bedouch P, Boignard A, Bouvaist H, Briault A, Camara B, Chanoine S, Dubuc M, Quétant S, Maurizi J, Pavèse P, Pison C, Saint‐Raymond C, Wion N, Chérion C, Grima R, Jegaden O, Maury J, Tronc F, Flamens C, Paulus S, Philit F, Senechal A, Glérant J, Turquier S, Gamondes D, Chalabresse L, Thivolet‐Bejui F, Barnel C, Dubois C, Tiberghien A, Pimpec‐Barthes F, Bel A, Mordant P, Achouh P, Boussaud V, Méléard D, Bricourt M, Cholley B, Pezella V, Brioude G, D'Journo X, Doddoli C, Thomas P, Trousse D, Dizier S, Leone M, Papazian L, Bregeon F, Coltey B, Dufeu N, Dutau H, Garcia S, Gaubert J, Gomez C, Laroumagne S, Mouton G, Nieves A, Picard C, Rolain J, Sampol E, Secq V, Perigaud C, Roussel J, Senage T, Mugniot A, Danner I, Haloun A, Abbes S, Bry C, Blanc F, Lepoivre T, Botturi‐Cavaillès K, Loy J, Bernard M, Godard E, Royer P, Henrio K, Dartevelle P, Fabre D, Fadel E, Mercier O, Stephan F, Viard P, Cerrina J, Dorfmuller P, Feuillet S, Ghigna M, Hervén P, Le Roy Ladurie F, Le Pavec J, Thomas de Montpreville V, Lamrani L, Castier Y, Mordant P, Cerceau P, Augustin P, Jean‐Baptiste S, Boudinet S, Montravers P, Dauriat G, Jébrak G, Mal H, Marceau A, Métivier A, Thabut G, Lhuillier E, Dupin C, Bunel V, Falcoz P, Massard G, Santelmo N, Ajob G, Collange O, Helms O, Hentz J, Roche A, Bakouboula B, Degot T, Dory A, Hirschi S, Ohlmann‐Caillard S, Kessler L, Schuller A, Bennedif K, Vargas S, Bonnette P, Chapelier A, Puyo P, Sage E, Bresson J, Caille V, Cerf C, Devaquet J, Dumans‐Nizard V, Felten M, Fischler M, Si Larbi A, Leguen M, Ley L, Liu N, Trebbia G, De Miranda S, Douvry B, Gonin F, Grenet D, Hamid A, Neveu H, Parquin F, Picard C, Stern M, Bouillioud F, Cahen P, Colombat M, Dautricourt C, Delahousse M, D'Urso B, Gravisse J, Guth A, Hillaire S, Honderlick P, Lequintrec M, Longchampt E, Mellot F, Scherrer A, Temagoult L, Tricot L, Vasse M, Veyrie C, Zemoura L, Dahan M, Murris M, Benahoua H, Berjaud J, Le Borgne Krams A, Crognier L, Brouchet L, Mathe O, Didier A, Krueger T, Ris H, Gonzalez M, Aubert J, Nicod L, Marsland B, Berutto T, Rochat T, Soccal P, Jolliet P, Koutsokera A, Marcucci C, Manuel O, Bernasconi E, Chollet M, Gronchi F, Courbon C, Hillinger S, Inci I, Kestenholz P, Weder W, Schuepbach R, Zalunardo M, Benden C, Buergi U, Huber L, Isenring B, Schuurmans M, Gaspert A, Holzmann D, Müller N, Schmid C, Vrugt B, Rechsteiner T, Fritz A, Maier D, Deplanche K, Koubi D, Ernst F, Paprotka T, Schmitt M, Wahl B, Boissel J, Olivera‐Botello G, Trocmé C, Toussaint B, Bourgoin‐Voillard S, Séve M, Benmerad M, Siroux V, Slama R, Auffray C, Charron D, Lefaudeux D, Pellet J. Blood CD9 + B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2019; 19:3162-3175. [PMID: 31305014 DOI: 10.1111/ajt.15532] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Revised: 06/12/2019] [Accepted: 07/07/2019] [Indexed: 01/25/2023]
Abstract
Bronchiolitis obliterans syndrome is the main limitation for long-term survival after lung transplantation. Some specific B cell populations are associated with long-term graft acceptance. We aimed to monitor the B cell profile during early development of bronchiolitis obliterans syndrome after lung transplantation. The B cell longitudinal profile was analyzed in peripheral blood mononuclear cells from patients with bronchiolitis obliterans syndrome and patients who remained stable over 3 years of follow-up. CD24hi CD38hi transitional B cells were increased in stable patients only, and reached a peak 24 months after transplantation, whereas they remained unchanged in patients who developed a bronchiolitis obliterans syndrome. These CD24hi CD38hi transitional B cells specifically secrete IL-10 and express CD9. Thus, patients with a total CD9+ B cell frequency below 6.6% displayed significantly higher incidence of bronchiolitis obliterans syndrome (AUC = 0.836, PPV = 0.75, NPV = 1). These data are the first to associate IL-10-secreting CD24hi CD38hi transitional B cells expressing CD9 with better allograft outcome in lung transplant recipients. CD9-expressing B cells appear as a contributor to a favorable environment essential for the maintenance of long-term stable graft function and as a new predictive biomarker of bronchiolitis obliterans syndrome-free survival.
Collapse
Affiliation(s)
- Carole Brosseau
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Richard Danger
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - Maxim Durand
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Faculté de Médecine, Université de Nantes, Nantes, France
| | - Eugénie Durand
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - Aurore Foureau
- Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Philippe Lacoste
- Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Adrien Tissot
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France.,Faculté de Médecine, Université de Nantes, Nantes, France
| | - Antoine Roux
- Hôpital Foch, Suresnes, France.,Université Versailles Saint-Quentin-en-Yvelines, UPRES EA220, Versailles, France
| | | | | | - Sacha Mussot
- Centre Chirurgical Marie Lannelongue, Service de Chirurgie Thoracique, Vasculaire et Transplantation Cardiopulmonaire, Le Plessis Robinson, France
| | | | - Olivier Brugière
- Hôpital Bichat, Service de Pneumologie et Transplantation Pulmonaire, Paris, France
| | | | | | - Johanna Claustre
- Clinique Universitaire Pneumologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Université Grenoble Alpes, Inserm U1055, Grenoble, France
| | - Antoine Magnan
- Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Sophie Brouard
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Centre d'Investigation Clinique (CIC) Biothérapie, CHU Nantes, Nantes, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Boulate D, Kassegne T, Chenesseau J, Ammi M, Mussot S, Fabre D, Mitilian D, Crutu A, Temam S, Mercier O, Fadel E. P2.17-24 Minimally Invasive Surgery for Lung Cancer Improves Short Term Outcomes in Patients with History of Head and Neck Carcinoma. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
22
|
Barco S, Klok FA, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara M, Mayer E, Pepke-Zaba J, Simonneau G, Delcroix M, Lang IM. P2540Sex-specific differences in the clinical presentation, surgical complications, and course of chronic thromboembolic pulmonary hypertension. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Women are more susceptible to develop several forms of pulmonary hypertension, but they may have better survival rates than men. Sparse data are available concerning sex-specific differences in chronic thromboembolic pulmonary hypertension (CTEPH).
Purpose and methods
We investigated sex-specific differences in the clinical presentation of CTEPH, functional parameters, exposure to pulmonary endarterectomy (PEA), and survival.
Results
Women constituted half of the study population (N=679 treatment-naïve patients from the European CTEPH registry) and were characterized by a lower prevalence of some cardiovascular risk factors (e.g. prior acute coronary syndrome, smoking habit, chronic obstructive pulmonary disease), but more prevalent obesity, cancer, and thyroid diseases. Median age was 62 (IQR 50–73) years in women and 63 (IQR 53–70) in men. Women underwent PEA less often than men (54% vs 65%; Figure 1, Panel A) and were exposed to fewer additional cardiac procedures, notably coronary artery bypass graft surgery (0.5% vs. 9.5%). The prevalence of specific reasons for not being operated, including the patient's refusal and the proportion of proximal vs. distal lesions, did not differ between sexes. A total of 57 (17.0%) deaths in women and 70 (20.7%) in men were recorded over long-term follow-up. Female sex was positively associated with long-term survival (adjusted Hazard Ratio 0.66; 95% Confidence Interval 0.46–0.94). Short-term mortality was identical in the two groups (Figure 1, Panel B).
Conclusions
Women with CTEPH had a lower prevalence of cardiovascular risk factors and underwent PEA less frequently than men, who, in turn, were more often exposed to additional major cardiac surgery procedures. Women had more favorable long-term survival.
Acknowledgement/Funding
The CTEPH registry is supported by a research grant from Actelion Pharmaceuticals Ltd.
Collapse
Affiliation(s)
- S Barco
- University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - F A Klok
- University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - S V Konstantinides
- University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - P Dartevelle
- Hôpital Marie-Lannelongue, Paris-Sud Univ, Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Paris, France
| | - E Fadel
- Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
| | - D Jenkins
- Papworth Hospital NHS Trust, Department of Cardiothoracic Surgery, Cambridge, United Kingdom
| | - N H Kim
- University of San Diego, Division of Pulmonary and Critical Care Medicine, La Jolla, United States of America
| | - M Madani
- University of San Diego, Division of Cardiovascular and Thoracic Surgery, La Jolla, United States of America
| | - M Matsubara
- Okayama Medical Center, Department of Clinical Science, Okayama, Japan
| | - E Mayer
- Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany
| | - J Pepke-Zaba
- Papworth Hospital NHS Trust, Pulmonary Vascular Disease Unit, Cambridge, United Kingdom
| | - G Simonneau
- Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicetre, France
| | - M Delcroix
- University Hospitals (UZ) Leuven, Department of Pneumology, Leuven, Belgium
| | - I M Lang
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| |
Collapse
|
23
|
Issard J, Decante B, Guihaire J, Mitilian D, Boulate D, Mussot S, Fabre D, Fadel E, Mercier O. Evaluation of the Effects of the Correction of Hydroelectrolytic Disorders during Prolonged Ex-Vivo Lung Perfusion. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
24
|
Arthur J, Amsallem M, Guihaire J, Haddad F, Lamrani L, Feuillet S, Stephan F, Jais X, Humbert M, Simonneau G, Mercier O, Fadel E. Preoperative C-Reactive Protein Predicts Early Postoperative Outcomes after Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
25
|
Guimaron S, Guihaire J, Amsallem M, Potier A, Amatogauberville A, Mabille L, Isorni M, Lamrani L, Fadel E, Mercier O. Right Ventricular Reverse Remodeling after Pulmonary Endarterectomy in Patients with Chronic Thrombo Embolic Pulmonary Hypertension. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
26
|
Boulate D, Guinard S, Bouvier A, Mussot S, Mitilian D, Fabre D, Mercier O, Fadel E. P2.16-26 Lung Cancer Resection in Patients with Criteria for Lung Cancer Screening Provides Satisfactory Short Term Results. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Taniguchi Y, Jais X, Boucly A, Weatherald J, Jevnikar M, Brenot P, Planche O, Parent F, Savale L, Montani D, Fadel E, Humbert M, Simonneau G, Sitbon O. P2614Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - X Jais
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | - A Boucly
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | | | - M Jevnikar
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | - P Brenot
- Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
| | - O Planche
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | - F Parent
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | - L Savale
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | - D Montani
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | - E Fadel
- Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
| | - M Humbert
- Hopital Bicetre, Le Kremlin-Bicetre, France
| | | | - O Sitbon
- Hopital Bicetre, Le Kremlin-Bicetre, France
| |
Collapse
|
28
|
Etienne H, Mercier O, Le Pavec J, Fabre D, Mussot S, Mitilian D, Fadel E. Lobar Lung Transplantation from Brain-dead Donors in Pulmonary Hypertension. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
29
|
Hascoet S, Pontailler M, Mercier O, Fabre D, Mussot S, Humbert M, Simonneau G, Jais X, Sitbon O, Fadel E. Outcome of Heart-Lung or Double-Lung Transplantation in Pulmonary Hypertension Secondary to Congenital Heart Diseases. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.597] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
30
|
Guimaron S, Guihaire J, Amsallem M, Athur-Ataam J, Amato-Gauberville A, Isorni M, Mabille L, Potier A, Arthur-Ataam S, Dorfmüller P, Lamrani L, Deleuze P, Mussot S, Fadel E, Mercier O. Right Ventricular Remodeling in Chronic Thrombo-Embolic Pulmonary Hypertension. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
31
|
Noly P, Piquereau J, Arthur-Ataam J, Coblence M, Guihaire J, Fadel E, Mercier O. Mitochondrial Respiratory Function is Impaired in the Setting of Right Ventricular Remodeling Induced by Pressure Overload. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
32
|
Levy A, Omeiri A, Fadel E, Le Péchoux C. Radiotherapy for Tracheal–Bronchial Cystic Adenoid Carcinomas. Clin Oncol (R Coll Radiol) 2018; 30:39-46. [DOI: 10.1016/j.clon.2017.10.012] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2017] [Revised: 09/27/2017] [Accepted: 09/29/2017] [Indexed: 12/11/2022]
|
33
|
Gerardin B, Glorion M, Rodriguez A, Garcia C, Stephan F, Fabre D, Mercier O, Brenot P, Fadel E. [Massive pulmonary embolism. When medical treatment is not enough]. Ann Cardiol Angeiol (Paris) 2017; 66:453-459. [PMID: 29122207 DOI: 10.1016/j.ancard.2017.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Emergency bedside veno-arterious ECMO implantation can be the only saving gesture in the suspicion of acute massive pulmonary embolism leading to haemodynamic failure, even before CT-scan imaging. Once the massive pulmonary embolism is confirmed it is possible to undergo surgical or percutaneous pulmonary thrombectomy, when thrombolytic therapy is contraindicated.
Collapse
Affiliation(s)
- B Gerardin
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France.
| | - M Glorion
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| | - A Rodriguez
- Hôpital du Kremlin-Bicêtre, 78, avenue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France
| | - C Garcia
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| | - F Stephan
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| | - D Fabre
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| | - O Mercier
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| | - P Brenot
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| | - E Fadel
- Hôpital Marie-Lannelongue, 133, avenue de la résistance, 92350 Le Plessis Robinson, France
| |
Collapse
|
34
|
Fadel E. MS 11.03 Surgical Approaches in Superior Sulcus Tumor. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
35
|
Glorion M, Polard V, Favereau F, Hauet T, Zal F, Fadel E, Sage E. Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO 2life ® in pig lung transplantation model. Artif Cells Nanomed Biotechnol 2017; 46:1773-1780. [PMID: 29069926 DOI: 10.1080/21691401.2017.1392315] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
We describe the results of adding a new biological agent HEMO2life® to a standard preservation solution for hypothermic static lung preservation aiming to improve early functional parameters after lung transplantation. HEMO2life® is a natural oxygen carrier extracted from Arenicola marina with high oxygen affinity developed as an additive to standard organ preservation solutions. Standard preservation solution (Perfadex®) was compared with Perfadex® associated with HEMO2life® and with sham animals after 24 h of hypothermic preservation followed by lung transplantation. During five hours of lung reperfusion, functional parameters and biomarkers expression in serum and in bronchoalveolar lavage fluid (BALF) were measured. After five hours of reperfusion, HEMO2life® group led to significant improvement in functional parameters: reduction of graft vascular resistance (p < .05) and increase in graft oxygenation ratio (p < .05). Several ischemia-reperfusion related biomarkers showed positive trends in the HEMO2life® group: expression of HMG B1 in serum tended to be lower in comparison (2.1 ± 0.8 vs. 4.6 ± 1.5) with Perfadex® group, TNF-α and IL-8 in BALF were significantly higher in the two experimental groups compared to control (p < .05). During cold ischemia, expression of HIF1α and histology remained unchanged and similar to control. Supplementation of the Perfadex® solution by an innovative oxygen carrier HEMO2life® during hypothermic static preservation improves early graft function after prolonged cold ischemia in lung transplantation.
Collapse
Affiliation(s)
- M Glorion
- a Laboratoire de Chirurgie Expérimentale , Université PARIS XI, Hôpital Marie Lannelongue , Le Plessis Robinson , France.,b Department of Thoracic Surgery and Lung Transplantation , Foch Hospital , Suresnes , France
| | - V Polard
- c HEMARINA S.A. , Morlaix , France
| | - F Favereau
- d Faculté de Médecine, Université de Poitiers, INSERM U927 , Poitiers , France
| | - T Hauet
- d Faculté de Médecine, Université de Poitiers, INSERM U927 , Poitiers , France
| | - F Zal
- c HEMARINA S.A. , Morlaix , France
| | - E Fadel
- a Laboratoire de Chirurgie Expérimentale , Université PARIS XI, Hôpital Marie Lannelongue , Le Plessis Robinson , France
| | - E Sage
- a Laboratoire de Chirurgie Expérimentale , Université PARIS XI, Hôpital Marie Lannelongue , Le Plessis Robinson , France.,b Department of Thoracic Surgery and Lung Transplantation , Foch Hospital , Suresnes , France
| |
Collapse
|
36
|
Fallatah A, Tayeb H, Sahly A, Talukder A, Alansari Y, Zahid H, Fadel E, Alansari T, Badwailan A. The yield of routine electroencephalography in the adult ICU: Experience from a tertiary hospital in Saudi Arabia. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
37
|
Taniguchi Y, Brenot P, Jais X, Garcia C, Planche O, Fadel E, Humbert M, Simonneau G. P4005Poor subpleural perfusion as a predictor of failure after balloon pulmonary angioplasty for non-operable chronic thromboembolic pulmonary hypertension. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Girerd B, Montani D, Jais X, Levy M, Savale L, Dorfmuller P, Lau E, Le Pavec J, Parent F, Bonnet D, Soubrier F, Fadel E, Sitbon O, Simonneau G, Humbert M. 5022Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Mercier O, Lepavec J, Langer N, Lamrani L, Mussot S, Fabre D, Lebret E, Laverdure F, Tachon G, Patrascu A, Viard P, Stephan F, Dartevelle P, Fadel E. Left Atrial Pressure Continuous Monitoring Improves Early Postoperative Outcomes After Double Lung Transplantation for Pulmonary Hypertension. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.1160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
40
|
Godinas L, Lepavec J, de Montpreville V, Ghigna M, Mussot S, Mercier O, Fadel E, Dorfmüller P. Increased Interstitial Neutrophils in Lung Transplant Recipients with Donor Specific Antibodies as a Potential Marker of Subclinical AMR-Related Events. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.1504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
41
|
Dartevelle PG, Mitilian D, Fadel E. Extended surgery for T4 lung cancer: a 30 years’ experience. Gen Thorac Cardiovasc Surg 2017; 65:321-328. [DOI: 10.1007/s11748-017-0752-6] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2016] [Accepted: 01/11/2017] [Indexed: 12/14/2022]
|
42
|
Deuse T, Guihaire J, Fadel E, Reichenspurner H, Robbins R, Schrepfer S. Macrophages Infiltration is Associated with Maladaptive Remodeling of the Right Ventricle in an Experimental Model of Pulmonary Hypertension. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- T. Deuse
- Universitäres Herzzentrum Hamburg, Herzchirurgie, Hamburg, Germany
| | - J. Guihaire
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| | - E. Fadel
- Marie Lannelongue Hospital, Thoracic and Vascular Surgery and Heart-Lung Transplantation, Paris, France
| | | | - R.C. Robbins
- Stanford University, Cardiac Surgery, Stanford, United States
| | - S. Schrepfer
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| |
Collapse
|
43
|
Deuse T, Guihaire J, Itagaki R, Hua X, Stubbendorf M, Fadel E, Dorfmueller P, Laenger F, Robbins R, Reichenspurner H, Schrepfer S. T Cell-Mediated Expression of S100A4 Is Associated with Cartilage Disruption in Transplanted Bronchi. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- T. Deuse
- Universitäres Herzzentrum Hamburg, Herzchirurgie, Hamburg, Germany
| | - J. Guihaire
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| | - R. Itagaki
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| | - X. Hua
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| | - M. Stubbendorf
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| | - E. Fadel
- Marie Lannelongue Hospital, Thoracic and Vascular Surgery and Heart-Lung Transplantation, Paris, France
| | - P. Dorfmueller
- Marie Lannelongue Hospital, Thoracic and Vascular Surgery and Heart-Lung Transplantation, Paris, France
| | - F. Laenger
- Medizinische Hochschule Hannover, Pathology, Hannover, Germany
| | - R.C. Robbins
- Stanford University, Cardiac Surgery, Stanford, United States
| | | | - S. Schrepfer
- Universitäres Herzzentrum Hamburg, TSI Lab, Hamburg, Germany
| |
Collapse
|
44
|
Abstract
Though most paragangliomas arise as sporadic tumors, the recent advantages in the genetic screening revealed that about 30 % of paragangliomas are linked to hereditary mutations, such as those involving SDH genes. A 22-year-old woman carrying a left main bronchus tumor underwent surgery in our institution. Her past medical history included a GIST without KIT or PDGFRA mutation. The histological examination revealed a nested proliferation of medium-sized cells expressing neuroendocrine markers (chromogranin A and synaptophysin). The neoplastic cells failed to express SDHB gene product. These findings led us to the final diagnosis of bronchial paraganglioma in the setting of Carney-Stratakis syndrome. Bronchial paragangliomas are exceedingly rare tumors with polymorphous clinical presentation, and usually benign clinical course. Though most paragangliomas are sporadic, some tumors are associated with specific hereditary disease, especially those occurring in young patients or in combination with other neoplasms.
Collapse
Affiliation(s)
- M R Ghigna
- Pathology Department, Marie Lannelongue Hospital, 133 Avenue de la Resistance, Le Plessis Robinson, 92350, France.
| | - P Dorfmuller
- Pathology Department, Marie Lannelongue Hospital, 133 Avenue de la Resistance, Le Plessis Robinson, 92350, France
| | - A Crutu
- Thoracic and Vascular Surgery Department, Marie Lannelongue Hospital, 92350, Le Plessis Robinson, France
| | - E Fadel
- Thoracic and Vascular Surgery Department, Marie Lannelongue Hospital, 92350, Le Plessis Robinson, France
| | - V Thomas de Montpréville
- Pathology Department, Marie Lannelongue Hospital, 133 Avenue de la Resistance, Le Plessis Robinson, 92350, France
| |
Collapse
|
45
|
Omeiri A, Lévy A, Fadel E, Le Péchoux C. Résultats de l’irradiation des carcinomes adénoïdes kystiques thoraciques. Cancer Radiother 2016. [DOI: 10.1016/j.canrad.2016.08.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Moser B, Fadel E, Fabre D, Keshavjee S, De Perrot M, Thomas P, Brioude G, Van Raemdonck D, Viskens S, Lang-Lazdunski L, Bille A, Weder W, Jungraithmayr W, Ruffini E, Guerrera F, Gómez De Antonio D, Liberman M, Novoa N, Scarci M, Janik S, Klepetko W. B-005SURGICAL THERAPY OF THYMIC TUMOURS WITH PLEURAL INVOLVEMENT: AN ESTS THYMIC WORKING GROUP SURVEY. Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
47
|
Ausin P, Le Pavec J, Feuillet S, Dorfmuller P, Mussot S, Savale L, Mercier O, Nunes H, Valeyre D, Fadel E. Clinical and Pathologic Features in Lung or Heart and Lung Transplanted Patients with a Diagnosis of Pulmonary Sarcoidosis. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.1019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
48
|
Gruner A, Kortchinsky T, Mercier O, Rezaiguia-Delclaux S, Fadel E, Stephan F. Outcome of Patients with End-Stage Pulmonary Hypertension Who Received Double Lung Transplantation Instead of Heart-Lung Transplantation: A Comparative Retrospective Study. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
49
|
Belkhir F, Levy A, Suissa A, Grellier-Adedjouma N, Xu P, Fadel E, Le Péchoux C. PO-0682: Prognostic factors and patterns of failure after post-op radiotherapy for epithelial thymic tumors. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31932-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
50
|
Marien L, Mercier O, Le Pavec J, Guihaire J, Mussot S, Fabre D, Lamrani L, Dartevelle P, Fadel E. Long-Term Outcome of Double Lung Retransplantation After Heart and Lung Transplantation for Chronic Lung Allograft Dysfunction. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|